MANE Veradermics, Incorporated
$98.97▲ +0.85%
Healthcare
Other
After hours
$99.50▲ +0.54%
Sep 11, 5:03 PM ET
Volume 575.8K
Avg Volume (10D) 492.7K
Key Metrics & Fundamentals
Market Cap
$4.13B
P/E Ratio
–
Div Yield
–%
52W Range
32.00 - 131.24
% vs 50 MA
-8.58%
% vs 200 MA
–%
RSI-14
43.9
MACD Histogram
+0.0300
Beta (1Y vs SPY)
0.99
Free Cash Flow
-$14.51M
Gross Rev
$0
Gross Profit
$0
EBITDA
-$29.55M
COGS
–
Operating Exp
$29.55M
Operating Income
-$29.55M
EBIT
-$29.55M
Pretax Income
-$23.50M
Net Income
-$23.50M
EPS (Diluted)
-0.58
Price & Volume History
Loading chart…
Recent News
Baldness Drug Stocks like Veradermics (MANE) and Absci (ABSI) Are Chasing the Same Wall Street Magic as Ozempic
Insider Monkey · Sep 12, 2026 12:29 AM
Veradermics to Present at Upcoming September Investor Conferences
Business Wire · Sep 3, 2026 9:33 PM
Veradermics (MANE) Stock Looks Overvalued After Its 161% Rally
Simply Wall St. · Sep 3, 2026 1:06 AM
Is Veradermics (MANE) Still Undervalued After Its 161% Year To Date Run?
Simply Wall St. · Sep 2, 2026 10:15 PM
Hair Loss Biotechs Emerge As Wall Street's Newest Growth Trade
BeInCrypto · Aug 31, 2026 3:21 AM
Veradermics Insider Sold Shares Worth $10,711,700, According to a Recent SEC Filing
MT Newswires · Aug 17, 2026 8:02 AM
Veradermics: Q2 Earnings Snapshot
Associated Press · Aug 11, 2026 10:11 PM
Veradermics Reports Second Quarter 2026 Financial Results and Highlights Recent Corporate and Clinical Progress
Business Wire · Aug 11, 2026 11:30 AM
Veradermics (MANE) Positioned to Disrupt Hair Loss Market
Insider Monkey · Aug 4, 2026 3:08 PM
Veradermics' Oral Hair Loss Drug for Women Shows Results In Just 2 Months
Benzinga · Jul 19, 2026 7:31 PM
Financial Overview - Income Statement
Quarterly
No financial data available. Click Refresh on the ticker to load latest fundamentals.
See MANE's money flow as a full page
Social Sentiment
No Reddit posts found for MANE.
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.